TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LUCD

Lucid Diagnostics Inc

Healthcare · Medical Devices

0.7857$ +0.7% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Lucid Diagnostics Inc (LUCD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.7% of the shares are freely tradable; institutional investors hold 19.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 19.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 26.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 73.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 8.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 191Mio.

Largest Shareholders

Institutions

Institutions LUCD
Name Stake (%) Shares Change (%) Date
BlackRock Inc 2.43 4,638,243 +7.6 03/31/2026
Vanguard Capital Management, LLC 2.18 4,154,770 +0.0 03/31/2026
Masters Capital Management LLC 2.09 4,000,000 +0.0 06/30/2026
Aberdeen Group PLC 2.00 3,822,997 +4.9 06/30/2026
Two Seas Capital LP 1.57 3,000,000 +0.0 03/31/2026
Geode Capital Management, LLC 1.18 2,245,350 +10.8 03/31/2026

Funds

Funds LUCD
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.38 4,547,002 +0.0 07/31/2026
abrdn Healthcare Opportunities 2.00 3,822,997 +0.0 07/31/2026
iShares Russell 2000 ETF 1.84 3,513,887 -0.6 08/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.97 1,861,414 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?